Literature DB >> 15662003

Type 2 diabetes-a matter of beta-cell life and death?

Christopher J Rhodes1.   

Abstract

In type 2 diabetes, the beta cells of the pancreas fail to produce enough insulin to meet the body's demand, in part because of an acquired decrease in beta-cell mass. In adults, pancreatic beta-cell mass is controlled by several mechanisms, including beta-cell replication, neogenesis, hypertrophy, and survival. Here, I discuss evidence supporting the notion that increased beta-cell apoptosis is an important factor contributing to beta-cell loss and the onset of type 2 diabetes. Interestingly, a key signaling molecule that promotes beta-cell growth and survival, insulin receptor substrate 2 (IRS-2), is a member of a family of proteins whose inhibition contributes to the development of insulin resistance in the liver and other insulin-responsive tissues. Thus, the IRS-2 pathway appears to be a crucial participant in the tenuous balance between effective pancreatic beta-cell mass and insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15662003     DOI: 10.1126/science.1104345

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  300 in total

Review 1.  Mechanisms of non-apoptotic programmed cell death in diabetes and heart failure.

Authors:  Gerald W Dorn
Journal:  Cell Cycle       Date:  2010-09-07       Impact factor: 4.534

2.  Endoplasmic reticulum overcrowding as a mechanism of beta-cell dysfunction in diabetes.

Authors:  F Despa
Journal:  Biophys J       Date:  2010-04-21       Impact factor: 4.033

Review 3.  Mitochondrial dynamics in diabetes.

Authors:  Yisang Yoon; Chad A Galloway; Bong Sook Jhun; Tianzheng Yu
Journal:  Antioxid Redox Signal       Date:  2010-08-26       Impact factor: 8.401

4.  Apoptosis Repressor With Caspase Recruitment Domain Ameliorates Amyloid-Induced β-Cell Apoptosis and JNK Pathway Activation.

Authors:  Andrew T Templin; Tanya Samarasekera; Daniel T Meier; Meghan F Hogan; Mahnaz Mellati; Michael T Crow; Richard N Kitsis; Sakeneh Zraika; Rebecca L Hull; Steven E Kahn
Journal:  Diabetes       Date:  2017-07-20       Impact factor: 9.461

5.  Ciliary neurotrophic factor protects mice against streptozotocin-induced type 1 diabetes through SOCS3: the role of STAT1/STAT3 ratio in β-cell death.

Authors:  Luiz F Rezende; Gustavo J Santos; Everardo M Carneiro; Antonio C Boschero
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

6.  Regulation of insulin secretion, glucokinase gene transcription and beta cell proliferation by adipocyte-derived Wnt signalling molecules.

Authors:  S Schinner; F Ulgen; C Papewalis; M Schott; A Woelk; A Vidal-Puig; W A Scherbaum
Journal:  Diabetologia       Date:  2007-11-10       Impact factor: 10.122

7.  Noncanonical activation of Akt/protein kinase B in {beta}-cells by the incretin hormone glucose-dependent insulinotropic polypeptide.

Authors:  Scott B Widenmaier; Arthur V Sampaio; T Michael Underhill; Christopher H S McIntosh
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

Review 8.  Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

Authors:  Shaodong Guo
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

Review 9.  Targeting the pancreatic β-cell to treat diabetes.

Authors:  Amedeo Vetere; Amit Choudhary; Sean M Burns; Bridget K Wagner
Journal:  Nat Rev Drug Discov       Date:  2014-02-14       Impact factor: 84.694

10.  Targeting Nrf2 by dihydro-CDDO-trifluoroethyl amide enhances autophagic clearance and viability of β-cells in a setting of oxidative stress.

Authors:  Wenjuan Li; Weiwei Wu; Haibo Song; Fang Wang; Huanjie Li; Li Chen; Yimu Lai; Joseph S Janicki; Keith W Ward; Colin J Meyer; Xing Li Wang; Dongqi Tang; Taixing Cui
Journal:  FEBS Lett       Date:  2014-05-08       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.